Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FCT7V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,160
Award facts
- Contract value 100% obligated
- $39,160.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,160.12 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for RINVOQ ER 45 mg tablets (28-count unit of use packaging). This is a firm fixed-price, non-set-aside contract with a completion date of December 10, 2025, and performance will be executed at the contractor's Conshohocken, Pennsylvania facility. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other autoimmune conditions, representing the type of specialty pharmaceutical support critical to military and federal healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vehicle running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and the primary vendor for federal medical procurement, AmerisourceBergen Drug Corp fulfills orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to make multiple awards across separate regions, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCT7V?
SPE2DR26FCT7V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FCT7V worth?
The government has obligated $39,160 on SPE2DR26FCT7V.
Is contract SPE2DR26FCT7V an order under another contract?
Yes. SPE2DR26FCT7V is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT7V competed?
The extent of competition for SPE2DR26FCT7V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award